These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. On-label and off-label drug use in the treatment of endometriosis. Quaas AM; Weedin EA; Hansen KR Fertil Steril; 2015 Mar; 103(3):612-25. PubMed ID: 25637479 [TBL] [Abstract][Full Text] [Related]
24. The FDA Revises Boxed Warning For Fluoroquinolones-Again. Aschenbrenner DS Am J Nurs; 2016 Sep; 116(9):22-3. PubMed ID: 27560334 [No Abstract] [Full Text] [Related]
25. In brief: More fluoroquinolone warnings. Med Lett Drugs Ther; 2018 Aug; 60(1553):136. PubMed ID: 30133426 [No Abstract] [Full Text] [Related]
27. Fluoroquinolone prescribing in the United States: 1995 to 2002. Linder JA; Huang ES; Steinman MA; Gonzales R; Stafford RS Am J Med; 2005 Mar; 118(3):259-68. PubMed ID: 15745724 [TBL] [Abstract][Full Text] [Related]
28. Ten common questions (and their answers) about off-label drug use. Wittich CM; Burkle CM; Lanier WL Mayo Clin Proc; 2012 Oct; 87(10):982-90. PubMed ID: 22877654 [TBL] [Abstract][Full Text] [Related]
29. An antimicrobial stewardship program with a focus on reducing fluoroquinolone overuse. Wong-Beringer A; Nguyen LH; Lee M; Shriner KA; Pallares J Pharmacotherapy; 2009 Jun; 29(6):736-43. PubMed ID: 19476424 [TBL] [Abstract][Full Text] [Related]
30. Impact of hospital formularies on fluoroquinolone prescribing in emergency departments. Aspinall SL; Metlay JP; Maselli JH; Gonzales R Am J Manag Care; 2007 May; 13(5):241-8. PubMed ID: 17488189 [TBL] [Abstract][Full Text] [Related]
31. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey. Chen DT; Wynia MK; Moloney RM; Alexander GC Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1094-100. PubMed ID: 19697444 [TBL] [Abstract][Full Text] [Related]
32. Gatifloxacin therapy for children: an antibiotic still in the "back room". Marchant CD Clin Infect Dis; 2005 Aug; 41(4):479-80. PubMed ID: 16028154 [No Abstract] [Full Text] [Related]
33. Fluoroquinolones in children: poorly defined risk of joint damage. Prescrire Int; 2004 Oct; 13(73):184-6. PubMed ID: 15499700 [TBL] [Abstract][Full Text] [Related]
34. Common questions about the newer fluoroquinolone antibiotics. North DS Nurse Pract; 1999 Mar; 24(3):124-7. PubMed ID: 10100244 [No Abstract] [Full Text] [Related]
35. Adverse Events in Older Adults Taking Fluoroquinolones. Leipold A; Grupa T; Swanoski M Sr Care Pharm; 2020 Aug; 35(8):355-359. PubMed ID: 32718392 [TBL] [Abstract][Full Text] [Related]
36. Misuse and resistance to antibacterial drug products addressed in labeling. Osterholm MT Clin Infect Dis; 2000 Oct; 31(4):ii. PubMed ID: 11221680 [No Abstract] [Full Text] [Related]
37. FDA and the safe and appropriate antibiotic use of fluoroquinolones. Tillotson GS Lancet Infect Dis; 2016 Mar; 16(3):e11-2. PubMed ID: 26973315 [No Abstract] [Full Text] [Related]
38. Fluoroquinolone approved for cattle. J Am Vet Med Assoc; 1998 Sep; 213(6):779. PubMed ID: 9743711 [No Abstract] [Full Text] [Related]
39. Bayer seeks veterinary, industry backing before Baytril hearing. J Am Vet Med Assoc; 2002 May; 220(10):1436, 1438. PubMed ID: 12018362 [No Abstract] [Full Text] [Related]